CBD shows promise for Hard-to-Treat psychosis in major new trial
NCT ID NCT06778564
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding cannabidiol (CBD) to standard antipsychotic medication can improve symptoms in people experiencing their first episode of psychosis who haven't responded well to initial treatment. About 250 participants aged 16-40 will receive either CBD or a placebo for 6 weeks, alongside their usual medication. The goal is to see if CBD can enhance treatment response and confirm its safety in this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Cambridgeshire and Peterborough NHS Foundation Trust
Cambridge, United Kingdom
Contact Email: •••••@•••••
-
Charité Universitätsmedizin
Berlin, Germany
Contact
-
Geha Mental Health Center
Petah Tikva, Israel
Contact
-
Hospital General Universitario Gregorio Marañón
Madrid, Spain
Contact
-
Hospital Universitario Virgen del Rocío
Seville, Spain
Contact
-
Ludwig-Maximilian-University Munich
Munich, Germany
Contact Email: •••••@•••••
-
MedUni Vienna
Vienna, Austria
Contact
-
National and Kapodistrian University of Athens
Athens, Greece
Contact
-
Oxford Health NHS Foundation Trust
Oxford, United Kingdom
Contact
-
Psychiatric University Hospital (PUK), Zurich
Zurich, Switzerland
Contact
-
Shalvata Mental Health Center
Hod HaSharon, Israel
Contact
-
Sheba Medical Centre
Ramat Gan, Israel
Contact
-
Stichting Amsterdam UMC
Amsterdam, Netherlands
Contact
-
University Hospital Cologne
Cologne, Germany
Contact
-
University of Augsburg
Augsburg, Germany
Contact
-
University of Campania 'Luigi Vanvitelli'
Naples, Italy
Contact
-
West London NHS Trust
London, United Kingdom